SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's growth, ...
Organically Human on MSN1h
From Goose Droppings to Medical Discovery: How a Chicago Student Found a Cancer-Fighting CompoundA middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...
UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By ...
A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...
The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback